1/173
Looks like no tags are added yet.
Osteoarthritis (OA)
A degenerative joint disorder characterized by deterioration of articular cartilage, joint space narrowing, and bone changes or osteophyte formation, causing joint pain that worsens with activity and improves with rest, accompanied by brief morning stiffness lasting less than 30 minutes.
Osteophytes
Bony projections or bone spurs that develop along joint margins in osteoarthritis as a result of articular cartilage loss and reactive bone remodeling.

Heberden's and Bouchard's Nodes
Bony enlargements of the finger joints in osteoarthritis; Heberden's nodes occur at the distal interphalangeal (DIP) joints, while Bouchard's nodes occur at the proximal interphalangeal (PIP) joints.
Crepitus
A palpable or audible grating, crackling, or popping sound and sensation produced by the friction of rough articular cartilage or exposed bone during joint movement.
Subchondral Sclerosis
An increased density or thickening of bone beneath the articular cartilage, visible on X-rays alongside joint-space narrowing and osteophytes in osteoarthritis.
Rheumatoid Arthritis (RA)
A chronic, systemic autoimmune disease characterized by immune-mediated attack on the synovial membrane, causing symmetrical joint pain, warm tender swelling, and morning stiffness lasting longer than 1 hour.
Pannus
An abnormal proliferative layer of granulation tissue formed over the synovial membrane in rheumatoid arthritis that releases enzymes, eroding cartilage and bone and causing progressive joint deformities.

Swan Neck and Boutonniere Deformities
Characteristic finger joint deformities resulting from tendon and bone destruction in progressive rheumatoid arthritis.
Anti-CCP Antibodies
Anti-cyclic citrullinated peptide antibodies; a highly specific laboratory serological marker used to support the definitive diagnosis of rheumatoid arthritis.
DMARDs
Disease-Modifying Anti-Rheumatic Drugs (such as methotrexate, targeted synthetics, and biologics) used in rheumatoid arthritis to alter disease progression and prevent joint destruction, rather than solely relieving symptoms.
Systemic Lupus Erythematosus (SLE)
A multisystem autoimmune disorder in which immune complexes deposit in blood vessels and membranes, causing chronic inflammation triggered by factors such as pregnancy, sunlight, illness, or stress.

Malar Rash
A characteristic butterfly-shaped erythematous skin rash over the cheeks and bridge of the nose in patients with systemic lupus erythematosus, frequently provoked by photosensitivity.
Anti-dsDNA Antibodies
Autoantibodies directed against double-stranded DNA that are specific for systemic lupus erythematosus and correlate with active disease, particularly lupus nephritis.
Anti-Smith (anti-Sm) Antibodies
Autoantibodies directed against core ribonucleoproteins that serve as a highly specific diagnostic finding for systemic lupus erythematosus.
Lupus Nephritis
Renal inflammation resulting from immune complex deposition in systemic lupus erythematosus, requiring monitoring of proteinuria, serum creatinine, blood pressure, and peripheral edema.
Hydroxychloroquine
An antimalarial medication used as foundational, long-term oral maintenance therapy for most individuals diagnosed with systemic lupus erythematosus.
Scleroderma
A chronic autoimmune connective tissue disease marked by excessive collagen deposition, progressive tissue fibrosis, and vascular damage leading to skin thickening, hardening, and internal organ involvement.

CREST Syndrome
A limited cutaneous variant of systemic sclerosis characterized by the clinical constellation of Calcinosis cutis, Raynaud's phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasia.
Calcinosis Cutis
The deposition of insoluble calcium salts in the skin and subcutaneous tissues, corresponding to the letter 'C' in CREST syndrome.
Raynaud's Phenomenon
Reversible, episodic vasospasm of digital small blood vessels provoked by cold exposure or emotional stress, resulting in sequential ischemic color changes of the fingers and toes.
Esophageal Dysmotility
Smooth muscle fibrosis and atrophy in scleroderma leading to impaired peristalsis, lower esophageal sphincter incompetence, severe gastroesophageal reflux disease (GERD), and dysphagia.
Sclerodactyly
Thickening, hardening, and tightening of the skin on the fingers and hands, resulting in fixed flexion contractures and restricted digital mobility.
Telangiectasia
Visible, dilated, fragile superficial cutaneous and mucosal capillaries commonly found on the face, lips, tongue, and hands in scleroderma.
Scleroderma Renal Crisis
A medical emergency in systemic sclerosis characterized by sudden onset of malignant hypertension and acute kidney injury (AKI), treated urgently with angiotensin-converting enzyme (ACE) inhibitors.
Anti-Scl-70 Antibodies
Anti-topoisomerase I autoantibodies strongly associated with diffuse cutaneous systemic sclerosis and an elevated risk for developing interstitial pulmonary fibrosis.
Anti-RNA Polymerase III
A serological autoantibody marker in scleroderma associated with diffuse cutaneous involvement and a significantly increased risk of scleroderma renal crisis.
Gout
An inflammatory crystalline arthritis caused by hyperuricemia, leading to the deposition of monosodium urate crystals in joints and eliciting severe acute inflammatory flares.

Podagra
Acute gouty arthritis localized specifically to the first metatarsophalangeal (great toe) joint, marked by sudden nocturnal pain, intense erythema, warmth, and exquisite tenderness.

Tophi
Firm, visible nodular aggregates of monosodium urate crystals that develop in the subcutaneous tissue, joints, and cartilage of patients with chronic gout.
Joint Aspiration in Gout
The gold-standard diagnostic procedure showing needle-shaped, negatively birefringent monosodium urate crystals in synovial fluid under polarizing microscopy.
Colchicine
An anti-inflammatory drug used to manage and abort acute flares of gout by suppressing crystal-induced inflammation.
Allopurinol
A xanthine oxidase inhibitor used as chronic maintenance therapy in gout to lower serum uric acid synthesis and prevent recurrent crystalline flares.
Ankylosing Spondylitis (AS)
A chronic inflammatory spondyloarthropathy primarily affecting the sacroiliac joints and spine, causing inflammatory back pain that improves with exercise rather than rest, and progressive spinal fusion.
Enthesitis
Inflammation occurring at the anatomical insertion sites of tendons, ligaments, or joint capsules into bone, serving as a primary pathological feature in ankylosing spondylitis.
Uveitis
An acute extra-articular ocular inflammatory complication of ankylosing spondylitis characterized by unilateral eye pain, redness, photophobia, and blurred vision.
Fibromyalgia
A chronic centralized pain regulation disorder characterized by widespread musculoskeletal pain lasting at least 3 months, nonrestorative sleep, severe fatigue, and cognitive deficits ('fibro fog') without destructive joint inflammation.
Central Sensitization
A neurobiological state in fibromyalgia where the central nervous system amplifies sensory pain transmission signals, producing generalized hyperalgesia in the absence of active tissue or joint pathology.
Widespread Pain Index (WPI)
A clinical diagnostic score that counts the number of painful anatomical body regions reported over the preceding week to evaluate fibromyalgia.
Sjögren's Syndrome
A chronic autoimmune disease characterized by lymphocytic infiltration and destruction of exocrine moisture-producing glands, primarily causing keratoconjunctivitis sicca (dry eyes) and xerostomia (dry mouth).

Ehlers-Danlos Syndrome (EDS)
A group of inherited connective tissue disorders caused by defects in collagen synthesis and structure, clinically characterized by joint hypermobility, skin hyperelasticity, and tissue fragility.
Thyroid Gland
An endocrine organ located in the anterior neck below the cricoid cartilage that secretes triiodothyronine (T3), thyroxine (T4), and thyrocalcitonin (calcitonin).
Parathyroid Hormone (PTH)
A hormone secreted by the parathyroid glands in response to low serum calcium levels that targets the bones, kidneys, and intestines to elevate circulating blood calcium.
Calcitonin (Thyrocalcitonin)
A hormone released by the thyroid gland in response to rising blood calcium levels that promotes calcium deposition in bones and decreases calcium uptake in the kidneys.
Hypothyroidism
A disorder characterized by underproduction of thyroid hormones due to an underactive thyroid, presenting with a hypometabolic state and decreased metabolism.
Hashimoto's Thyroiditis
An autoimmune disorder causing destruction of the thyroid gland, identified as a primary autoimmune etiology of hypothyroidism.
Primary Hypothyroidism
A type of hypothyroidism resulting directly from a disorder of the thyroid gland itself, marked by decreased levels of T3 and T4 alongside increased thyroid-stimulating hormone (TSH).
Secondary Hypothyroidism
A type of hypothyroidism caused by dysfunction of the anterior pituitary gland, resulting in decreased T3 and T4 accompanied by normal or low TSH levels.
Tertiary Hypothyroidism
A type of hypothyroidism caused by dysfunction of the hypothalamus, characterized by decreased T3 and T4 with normal or low TSH levels.
Myxedema
A clinical feature of hypothyroidism consisting of fluid accumulation that produces generalized non-pitting edema.
Levothyroxine (Synthroid)
A synthetic thyroid hormone replacement medication taken in the morning with a full glass of water, requiring a 30-minute wait before eating or drinking coffee.
Myxedema Coma
A severe, life-threatening complication of hypothyroidism caused by critically decreased metabolism, presenting with hypoxia, carbon dioxide retention, hypothermia, hyponatremia, and hypoglycemia.
Hyperthyroidism
A hypermetabolic clinical condition characterized by the overproduction of thyroid hormones due to an overactive thyroid gland.
Grave's Disease
An autoimmune disorder in which autoantibodies bind to the thyroid gland, representing a major cause of hyperthyroidism commonly diagnosed between ages 20 and 40.
Exophthalmos
Abnormal protrusion of the eyes seen in hyperthyroidism that can cause visual changes.
Goiter
Hyperplasia or enlargement of the thyroid gland triggered by thyroid-stimulating hormone (TSH).
Propylthiouracil (PTU)
An oral antithyroid agent indicated for the long-term pharmacologic management of hyperthyroidism and used in the emergency management of thyroid storm.
Methimazole (Tapazole)
An antithyroid drug utilized as long-term medical therapy to suppress excess thyroid hormone production in hyperthyroidism.
Thyrotoxicosis (Thyroid Storm)
An acute, life-threatening complication of poorly managed hyperthyroidism manifesting with tachycardia, systolic hypertension, fever, tremors, abdominal pain, and altered level of consciousness.
Types of Thyroid Cancer
The four distinct histological categories of thyroid cancer: papillary, follicular, medullary, and anaplastic.
Fine Needle Aspiration (FNA) Biopsy
A diagnostic procedure using a slender needle to extract a small sample of fluid and tissue cells from a thyroid nodule for microscopic evaluation.
Pre-operative Iodine Administration
The clinical administration of iodine preparations prior to thyroidectomy to decrease the size and vascularity of the thyroid gland.
Post-operative Thyroidectomy Complications
Critical postoperative complications following thyroid excision that mandate immediate nursing assessment: airway compromise, hemorrhage, and hypocalcemia.
Hypoparathyroidism
A deficiency of parathyroid hormone (PTH) secretion that causes diminished osteoclastic activity and reduced calcium absorption, leading to hypocalcemia and hyperphosphatemia.

Chvostek Sign
A clinical indication of hypocalcemia characterized by ipsilateral facial muscle twitching following mechanical percussion of the facial nerve.

Trousseau Sign
A physical finding of hypocalcemia demonstrated by carpopedal spasm and involuntary hand flexion during arterial occlusion via an inflated blood pressure cuff.
Acute Hypocalcemia Management
Immediate intravenous calcium replacement therapy administered via Calcium Gluconate or Calcium Chloride in acute hypoparathyroidism.
Hyperparathyroidism
An endocrine disorder caused by excessive secretion of parathyroid hormone (PTH), resulting in systemic hypercalcemia and hypophosphatemia.
Parathyroid Adenoma
A benign neoplasm of the parathyroid gland that constitutes the primary underlying etiology of hyperparathyroidism.
Normal Serum Calcium Level
The standard physiological serum concentration of total blood calcium, with a reference range of 8.5-10.5mEq/L.
Normal Serum Phosphorus Level
The physiological reference laboratory value for serum phosphorus, maintaining a normal range of 2.5-4.5mEq/L.
Normal Serum TSH Level
The reference diagnostic laboratory parameter for thyroid-stimulating hormone, normally established between 0.4mcIU/mL and 4.2mcIU/mL.
Clinical Manifestations of Hyperparathyroidism
A cluster of signs and symptoms caused by hypercalcemia—often summarized as 'groans, bones, stones, thrones'—including anorexia, constipation, bone pain, kidney stones, and polyuria.
Polycythemia
A hematologic disorder defined by the production and presence of increased numbers of RBCs, leading to hyperviscosity and hypervolemia; diagnostic thresholds include Hct ≥52% and Hgb ≥18.5g/dL in men, and Hct ≥48% and Hgb ≥16.5g/dL in women.

Plethora
A ruddy, reddened facial complexion resulting from hyperviscosity and increased red blood cell volume, characteristically seen in patients with polycythemia.
Hydroxurea
A pharmacologic agent administered in the medical plan of care for polycythemia to depress bone marrow production of blood cells.
Thrombocytopenia
A condition characterized by a reduction in platelet count, caused by decreased production (cancers, medications, toxins), increased destruction (autoimmune, medications, infection), or increased consumption (major bleeding, DIC, heparin).
Idiopathic Thrombocytopenia Purpura (ITP)
A hematologic condition manifested by bruising, petechiae, and bleeding, which carries a critical complication of uncontrolled hemorrhage.

Petechiae
Small, pinpoint red or purple hemorrhages on the skin that appear as a clinical manifestation of thrombocytopenia and ITP.

Bone Marrow Biopsy and Aspiration
A diagnostic procedure involving needle insertion through the skin and cortical bone to aspirate and evaluate marrow cells for hematologic disorders including ITP, leukemia, and multiple myeloma.
Romiplostim (Nplate)
A platelet booster medication prescribed as part of medical therapy for patients with idiopathic thrombocytopenia purpura (ITP).
Leukemia
A blood cancer affecting the bone marrow wherein myeloid or lymphoid cells mutate into leukemic blast cells that proliferate continuously without maturing and ignore signals for apoptosis.
Acute Leukemias (AML and ALL)
Acute forms of leukemia—specifically acute myelogenous leukemia and acute lymphoblastic leukemia—characterized by a sudden, rapid onset of clinical symptoms.
Chronic Leukemias (CML and CLL)
Chronic forms of leukemia—specifically chronic myelogenous leukemia and chronic lymphoblastic leukemia—that present more subtly, persist for years, and later progress to display more acute symptoms.
Granulocyte Colony Stimulating Factors (GCSFs)
Subcutaneous injectable agents, such as filgrastim (Neupogen) and pegfilgrastim (Neulesta), administered to treat neutropenia resulting from chemotherapy and radiation.
Autologous Transplant
A stem cell or bone marrow transplantation procedure that utilizes the patient's own harvested cells to restore hematopoietic function.
Allogeneic Transplant
A stem cell or bone marrow transplantation procedure in which cells from a matched donor are infused to eradicate leukemic cells and restore marrow function.
Graft-versus-Host Disease (GVHD)
A complication of allogeneic bone marrow transplantation in which donor T cells launch an immune attack against the recipient host tissues.
Hodgkin's Lymphoma
A solid lymphoid malignancy that originates in a single lymph node of the neck, spreads locally, features Reed-Sternberg B-cells, and carries a higher survival rate.
Reed-Sternberg Cells
Characteristic abnormal, giant neoplastic B-cells whose diagnostic identification distinguishes Hodgkin's lymphoma from non-Hodgkin's lymphomas.
Non-Hodgkin's Lymphoma
A lymphoid malignancy originating in multiple lymph nodes across diverse sites, involving either B or T cells, that spreads extensively and carries a lower survival rate.
B Symptoms
A group of constitutional clinical manifestations seen in lymphoma consisting of low-grade fever, night sweats, chills, fatigue, and an unintentional weight loss of 10% or more within 6months.
Superior Vena Cava (SVC) Syndrome
A serious oncologic complication of lymphoma caused by mediastinal vascular compression, manifesting as chest pain, dyspnea, dysphagia, jugular venous distention (JVD), and facial and upper extremity swelling.
Multiple Myeloma
A hematologic cancer in which malignant plasma B cells proliferate uncontrollably, infiltrate bone marrow and other organs, and produce an abnormal monoclonal immunoglobulin.
Monoclonal Protein (M Protein)
An abnormal immunoglobulin antibody produced in excessive amounts by neoplastic plasma B cells in multiple myeloma, which destroys bone and drives blood hyperviscosity.
Bence Jones Protein
An abnormal protein present in the urinalysis of patients with multiple myeloma that serves as a key diagnostic laboratory marker.

Lytic Lesions
"Punched-out" radiographic areas of bone destruction caused by uncontrolled plasma cell proliferation in patients with multiple myeloma.
Bortezomib (Velcade)
An immune modifier medication utilized in the pharmacological medical management of multiple myeloma.
Apheresis
A therapeutic blood filtering procedure utilized in multiple myeloma to remove excess circulating M protein and reduce blood viscosity.
Plasma
The liquid matrix of whole blood, accounting for 55% of total volume, composed of 91% water, 7% proteins (albumin, globulin, fibrinogen), and 2% metabolic wastes, gases, electrolytes, and other substances.
Hematopoiesis
The process of blood cell formation and development that originates from pluripotent stem cells in the bone marrow, branching into myeloid and lymphoid stem cell lines.